| Literature DB >> 31467862 |
Nagarajan Kanipandian1,2, Deyu Li2, Soundarapandian Kannan1.
Abstract
In the past decade, the research communities raised wide concerns on using medicinal plants for synthesis of nanomaterials due to its effective biological activity, lower side effects and also eco-friendly manner. Our previous report concentrated on the biomedical efficacy of fine characterized silver nanoparticles (AgNPs) from Gossypium hirsutum (cotton) leaf extract. Further, the current examination is planned to reveal the molecular mechanisms involving for activation of mitochondria-mediated signaling pathway by AgNPs in human lung cancer cells (A549) using various biological endpoints such as apoptotic induction by HOECHST 33342, AO/EtBr and Rhodamine 123 staining, cell cycle analysis using flow cytometry, gene and protein expressions by RT-PCR and immunoblotting respectively. This study was further extended to identify the toxicity of AgNPs using an animal model. Interestingly, we observed that A549 cells treated with AgNPs resulted in G2/M arrest and ultimately leads to induction of apoptosis cell death. Moreover, gene analysis demonstrated that diminished expression of anti-apoptotic (Bcl-2) and enhanced expression of pro-apoptotic (Bax) mitochondrial genes. The alterations in the gene pattern may interrupt of mitochondrial membrane potential which facilitates the releasing of cytochrome c (cyt c) into cytosol. The cyt c act as a key molecule for activation of caspases (9 and 3) to initiate intrinsic apoptotic signaling cell death process. The histological analysis proven the application of AgNPs in nanomedicine is quietly harmless and would not cause any discernible stress like swelling and inflammation to the organs of mice. Taken together, this investigation may provide solid evidence for cotton crop mediated AgNPs induced apoptosis cell death pathway and offer a novel approach for cancer therapy.Entities:
Keywords: A549 cells; A549 cells, adenocarcinomic human alveolar basal epithelial cells; AO/EtBr, acridine Orange and Ethidium Bromide; AgNPs, silver nanoparticles; BSA, bovine serum albumin; Bax, Bcl-2-associated X protein; Bcl-2, B-cell Lymphoma; Cas 3 and Cas 9, Caspase 3 and Caspase 9; Cell cycle arrest; Cyt-c, cytochrome C; DLS, dynamic light scattering; DMEM, Dulbecco's modified eagles medium; DMSO, dimethyl sulfoxide; GC–MS, gas chromatography-mass spectrometry; Gossypium hirsutum; H&E, hematoxylin and eosin; Intrinsic apoptosis pathway; PBS, phosphate buffered saline; PCR, polymerase chain reaction; SDS-PAGE, SDS-polyacrylamide gel electrophoresis; Silver nanoparticles; mRNA, messenger ribonucleic acid; nm, nanometers; p53 gene, tumor suppressor gene; ΔΨ m, mitochondrial membrane potential; β-Actin, beta actin
Year: 2019 PMID: 31467862 PMCID: PMC6713847 DOI: 10.1016/j.btre.2019.e00339
Source DB: PubMed Journal: Biotechnol Rep (Amst) ISSN: 2215-017X
Fig. 1GC–MS Chromatogram for methanol leaf extract of G. hirsutum.
Characterization of AgNPs synthesized from aqueous leaf extract of Gossypium hirsutum.
| Methods used for Characterization | Observation |
|---|---|
| UV-visible spectroscopy | 410 nm |
| FTIR | Presence of proteins, phenolic compounds and silicon (Si-O-Si) may act as a reducing agent to form Ag ions |
| XRD | Face centered cubic structure (JCPDS File No: 03-0921) and crystalline nature with 13 nm size |
| EDX | Elemental constituents of silver (64.88 %), carbon (14.69 %), Chloride (10.29 %), oxygen (9 %) and calcium (1.14 %) |
| FESEM and HRTEM | Mono-dispersed nature and spherical in shape with size range between 13 to 40 nm |
| SAED | Confirm the crystalline nature of the silver nanoparticles |
Fig. 2Represents the HRTEM (A) Size (B) and Zeta potential of cotton leaf mediated AgNPs.
Profiling chemical constituents of G. hirsutum through GC–MS analysis.
| Peak# | R. Time | Area | Area% | Name |
|---|---|---|---|---|
| 1 | 7.617 | 583955 | 0.30 | 8-ISOPROPYL-1,3-DIMETHYLTRICYCLO[4.4.0.0˜2,7˜] |
| 2 | 8.120 | 11884797 | 6.07 | Caryophyllene |
| 3 | 8.402 | 368270 | 0.19 | 5,9-UNDECADIEN-2-ONE,6,10-DIMETHYL-,(E)- |
| 4 | 8.477 | 4251320 | 2.17 | 1,4,8-CYCLOUNDECATRIENE,2,6,6,9-TETRAMETHYL- |
| 5 | 8.900 | 272285 | 0.14 | |
| 6 | 9.030 | 672980 | 0.34 | Bicyclo[3.1.1]hept-2-ene,2,6-dimethyl-6-(4-methyl-3-penteny |
| 7 | 9.124 | 874454 | 0.45 | .beta.-Bisabolene |
| 8 | 9.267 | 4078334 | 2.08 | D-Allose |
| 9 | 9.499 | 3215656 | 1.64 | Dodecanoicacid |
| 10 | 9.730 | 3777187 | 1.93 | Caryophylleneoxide |
| 11 | 9.960 | 1151273 | 0.59 | |
| 12 | 10.032 | 853161 | 0.44 | .alpha.- |
| 13 | 10.191 | 1765188 | 0.90 | Caryophylleneoxide |
| 14 | 10.401 | 6539998 | 3.34 | .beta.-bisabolol |
| 15 | 10.592 | 479959 | 0.25 | 3-Buten-2-one,4-(4-hydroxy-2,2,6-trimethyl-7-oxabicyclo[4.1 |
| 16 | 10.760 | 793106 | 0.41 | 2-Cyclohexen-1-one,4-(3-hydroxybutyl)-3,5,5-trimethyl- |
| 17 | 11.068 | 1504771 | 0.77 | Tetradecanoicacid |
| 18 | 11.158 | 978029 | 0.50 | MYRACALDEHYDE1AND2 |
| 19 | 11.330 | 5070493 | 2.59 | 3-Buten-2-ol,2-methyl-4-(1,3,3-trimethyl-7-oxabicyclo[4.1.0] |
| 20 | 11.568 | 13840588 | 7.07 | 2,6,10-TRIMETHYL,14-ETHYLENE-14-PENTADECNE |
| 21 | 11.726 | 3423698 | 1.75 | |
| 22 | 11.862 | 3166693 | 1.62 | 2-HEXADECEN-1-OL,3,7,11,15-TETRAMETHYL-,[R-[R |
| 23 | 12.160 | 3256937 | 1.66 | Hexadecanoicacid,methylester |
| 24 | 12.467 | 20632200 | 10.54 | n-Hexadecanoicacid |
| 25 | 12.700 | 1020294 | 0.52 | 2,6,10-Dodecatrien-1-ol,3,7,11-trimethyl- |
| 26 | 12.891 | 1309589 | 0.67 | GERANYLLINALOOLISOMER |
| 27 | 13.327 | 1939100 | 0.99 | 9,12,15-Octadecatrienoicacid,methylester,(Z,Z,Z)- |
| 28 | 13.400 | 8593632 | 4.39 | Phytol |
| 29 | 13.617 | 5352556 | 2.73 | 9,12,15-Octadecatrienoicacid,(Z,Z,Z)- |
| 30 | 13.713 | 605854 | 0.31 | Octadecanoicacid |
| 31 | 13.912 | 1725351 | 0.88 | Hexadeca-2,6,10,14-tetraen-1-ol,3,7,11,16-tetramethyl- |
| 32 | 14.042 | 815734 | 0.42 | 4,5,6,7-TETRAETHYL-1-METHYLINDANE |
| 33 | 14.350 | 1473472 | 0.75 | 2,6,10-Dodecatrien-1-ol,12-acetoxy-2,6,10-trimethyl-,(E,E,E |
| 34 | 14.641 | 1948533 | 1.00 | cis-9-Hexadecenal |
| 35 | 14.764 | 444061 | 0.23 | Cyclohexane,tetradecyl- |
| 36 | 14.857 | 681232 | 0.35 | 4,8,12,16-Tetramethylheptadecan-4-olide |
| 37 | 15.000 | 938872 | 0.48 | 5,9,13-Pentadecatrien-2-one,6,10,14-trimethyl-,(E,E)- |
| 38 | 15.366 | 303529 | 0.16 | 1,6,10,14,18,22-Tetracosahexaen-3-ol,2,6,10,15,19,23-hexa |
| 39 | 15.586 | 1396225 | 0.71 | Hexadecanoicacid,trimethylsilylester |
| 40 | 15.716 | 640220 | 0.33 | Hexadecanoicacid,2-hydroxy-1-(hydroxymethyl)ethylester |
| 41 | 15.886 | 923212 | 0.47 | Bis(2-ethylhexyl)phthalate |
| 42 | 15.975 | 473608 | 0.24 | CYCLOHEXANONE,2,6-BIS(PHENYLMETHYLENE)- |
| 43 | 16.550 | 1011252 | 0.52 | 2-methylhexacosane |
| 44 | 16.648 | 237719 | 0.12 | 9,19-Cyclolanostan-3-ol,acetate,(3.beta.)- |
| 45 | 16.723 | 329362 | 0.17 | Formicacid,3,7,11-trimethyl-1,6,10-dodecatrien-3-ylester |
| 46 | 17.029 | 681555 | 0.35 | 2-methylhexacosane |
| 47 | 17.226 | 15110297 | 7.72 | Squalene |
| 48 | 17.406 | 1789642 | 0.91 | Cyclohexane,1,2,3,5-tetraisopropyl- |
| 49 | 17.497 | 4339880 | 2.22 | Tetratetracontane |
| 50 | 17.659 | 412950 | 0.21 | |
| 51 | 17.725 | 948319 | 0.48 | NERYLLINALOOLISOMER |
| 52 | 17.833 | 858417 | 0.44 | |
| 53 | 17.967 | 814440 | 0.42 | PENTALENE,OCTAHYDRO-1-(2-OCTYLDECYL)- |
| 54 | 18.115 | 1743851 | 0.89 | 1,6,10,14,18,22-Tetracosahexaen-3-ol,2,6,10,15,19,23-hexa |
| 55 | 18.278 | 471811 | 0.24 | .beta.-Tocopherol |
| 56 | 18.389 | 2138161 | 1.09 | Tetratetracontane |
| 57 | 18.460 | 1308405 | 0.67 | 1-Triacontanol |
| 58 | 18.606 | 605150 | 0.31 | Cholesta-4,6-dien-3-ol,(3.beta.)- |
| 59 | 18.758 | 8832148 | 4.51 | Vitamin E |
| 60 | 19.242 | 529283 | 0.27 | SOLANESOL |
| 61 | 19.477 | 759746 | 0.39 | |
| 62 | 19.549 | 865411 | 0.44 | 1-Heptacosanol |
| 63 | 19.665 | 2761176 | 1.41 | Stigmasterol |
| 64 | 19.864 | 170541 | 0.09 | ARNOTHIANAMIDE |
| 65 | 20.049 | 10258322 | 5.24 | STIGMAST-5-EN-3-OL,(3.BETA.)- |
| 66 | 20.172 | 989293 | 0.51 | Fucosterol |
| 67 | 20.401 | 4643699 | 2.37 | .beta.-Amyrin |
| 68 | 20.573 | 919433 | 0.47 | 4,4,6A,6B,8A,11,11,14B-OCTAMETHYL-1,4,4A,5,6,6A,6 |
| 69 | 20.769 | 5978914 | 3.05 | .alpha.-Amyrin |
| 70 | 21.111 | 1001969 | 0.51 | Cholest-4-en-3-ol |
| 71 | 21.359 | 574185 | 0.29 | Phytol,acetate |
| 72 | 22.544 | 351682 | 0.18 | SOLANESOL |
| 73 | 22.875 | 252974 | 0.13 | 2,2,4-Trimethyl-3-(3,8,12,16-tetramethyl-heptadeca-3,7,11,15 |
| 195710393 | 100.00 |
Fig. 3Fluorescence microscopy images of control and silver nanoparticles treated A549 cells. The apoptosis induction by HOECHST-33342, AO/EtBr staining and loss of mitochondrial membrane potential by Rh-123 staining at different time intervals (24, 48 and 72 h).
Fig. 4(A) Flow cytometric analysis of cell cycle distribution of AgNPs treated and control A549 cells for 24, 48 and 72 h (B) depicts the cellular DNA histograms of A549 cells were analyzed by the BD CELLQuest Pro.
Fig. 5(A) The semi-quantitative RT-PCR demonstrates the gene expression changes for Bax, Bcl-2, p53 and β-actin (B) Densitometry analysis of intrinsic apoptotic related gene expressions of A549 cells exposure to AgNPs for 24, 48 and 72 h. The results shown here are representative of three independent experiments. (C) Immunoblot showing the expression of apoptotic responsive proteins such as cyt c, caspases -9, caspases -3 and β-actin (D) Densitometry quantification of apoptotic protein expression. The results exhibited here are representative of three independent experiments. β-actin expression was used as a loading control.
Fig. 6In vivo toxicity investigation of AgNPs on mice organs such as liver, heart and kidney. The control group images are given in A, C and E and AgNPs treated images are in B, D and F.
Fig. 7Depict the histopathological observations of control and AgNPs treated group of mice. The histological analysis of brain, spleen, testis and lung demonstrate there is no significant difference between the control (A, C and E) and AgNPs treated (B, D and F) groups. This proves the insignificant toxicity of silver nanoparticles against the selected vital organs.